Healthcare ❯Pharmaceuticals ❯Weight Loss Drugs

GLP-1 Agonists

Zepbound Employer Coverage Ozempic

U.S. Obesity Rates Decline for First Time in Over a Decade

Ozempic Shows Promise Beyond Diabetes Treatment

Eli Lilly's Q1 Earnings Surge on Strong Zepbound and Mounjaro Sales